Showing results (151-160 of 221) with videos related to
Sort By:
Pageof 23
Gynecologic Oncology|May 25, 2021
Uterine carcinosarcomas: From pathology to practiceMichael D Toboni, Erin K Crane, Jubilee Brown, et al.Cancer|August 4, 2010
A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinomaBrian M Slomovitz, Karen H Lu, Taren Johnston, et al.Journal of Surgical Oncology|January 18, 2011
The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patientsHaider Mahdi, Melissa Thrall, Sanjeev Kumar, et al.Biorxiv : the Preprint Server for Biology|May 3, 2023
A core NRF2 gene set defined through comprehensive transcriptomic analysis predicts selective drug resistance and poor multi-cancer prognosisGeorge Luo, Harshita Kumar, Kristin Alridge, et al.Gynecologic Oncology|April 25, 2013
Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical centerJessica Moline, Haider Mahdi, Bin Yang, et al.American Journal of Obstetrics and Gynecology|August 16, 2024
Approach to radical hysterectomy for cervical cancer after the Laparoscopic Approach to Cervical Cancer trial and associated complications: a National Surgical Quality Improvement Program studyGabriel Levin, Pedro T Ramirez, Jason D Wright, et al.American Journal of Obstetrics and Gynecology|March 10, 2007
Reduced progression of endometrial hyperplasia with oral mTOR inhibition in the Pten heterozygote murine modelMichael R Milam, Joseph Celestino, Weiguo Wu, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2025
The new 2023 endometrial cancer FIGO staging system: balancing innovation with complexityEmilia Palmieri, Andrea Mariani, Robert Coleman, et al.Gynecologic Oncology|June 30, 2009
Racial disparities in survival among patients with germ cell tumors of the ovary--United StatesChristopher S Bryant, Sanjeev Kumar, Jay P Shah, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 31, 2023
The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinomaIsabelle Ray-Coquard, Bradley J Monk, Domenica Lorusso, et al.Pageof 23